1Camargo C, Smithline H A, Malice M P, et al. A randomized controlled trial of intravenous montelukast in acute asthma [ J ]. Am J Respir Crit Care Med, 2003,167(4) :528 -533.
2Jenkins C, Woolcock A J, Saarelainen P, et al. Seretide^TM (salmeterol 50 mg/fluticasone propionate 250 mg, bid) compared with budesonide (800 rag, bid) [J]. Respir Med, 2000, 94 (7):715 -723.
3Back M. Functional characteristics of cysteinyl-leukotriene receptor subtypes[J]. Life Sci, 2002,71 (4) :611 -622.
4Jamaleddine G, Diab K, Tabbarah Z, et al. Leukotriene antagonists and the churg-strauss syndrome [ J ]. Semin Arthritis Rheum, 2002, 31 (2) :218 -227.
5McFadden E. Acute severe asthma[ J]. Am J Respir Crit Care Med, 2003,168 ( 5 ) :740 - 759.
6Johnson M. The β-adrenoceptor [ J ]. Am J Respir Crit Care Med, 1998,158(1) :146 - 153.
7Pauwels R A, Sears M R, Campbell M, et al. Formoterol as relif medication in asthma: a worldwide safety and effectiveness trim [ J ]. Eur Respir J, 2003,22 ( 6 ) :787 - 794.
8OByrne P M. Pharmacologic interventions to reduce the risk of asthma exacerbations[ J]. Proc Am Thorac Soc, 2004,1 ( 1 ) : 105 - 108.
9Mendes E S, Pereira A, Danta I, et al. Comparative bronchial vasoconstractive efficacy of inhaled glucocorticosteroids [ J ]. Eeu Respir J, 2003,21 ( 8 ) :989 - 993.
10Lee-Wong M, Dayrit F M, Kohli A R, et al. Comparison of highdose inhaled flunisolide to systemic corticosteroids in severe adult asthma[J]. Chest, 2002,122(10) :1208 - 1213.
